Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 10, 2011, Pages 1495-1498

  Falkenstern Ge, R F ^a,b   Kimmich, M ^b   Friedel, G ^b   Tannapfel, A ^c   Neumann, V ^c   Kohlhaeufl, M ^b  

^a University of Tuebingen ^*  (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Hyperplasia; Neuroendocrine; Obstructive; Pulmonary nodules

Indexed keywords

BIOLOGICAL MARKER; CD56 ANTIGEN; STEROID;

AGED; ARTICLE; CASE REPORT; CELL HYPERPLASIA; CELL PROLIFERATION; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINE CELL HYPERPLASIA; DISEASE ASSOCIATION; DISEASE CONTROL; DOSE RESPONSE; DRUG DOSE REDUCTION; FIBROSING ALVEOLITIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LUNG INFILTRATE; LUNG LESION; LUNG NODULE; LUNG RESECTION; MALE; PNEUMONIA; PRIORITY JOURNAL; RARE DISEASE; RECURRENT DISEASE; SPIROMETRY; TOTAL LUNG CAPACITY; VIDEO ASSISTED THORACOSCOPIC SURGERY; WEDGE RESECTION;

AGED; CARCINOID TUMOR; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; LUNG NEOPLASMS; MALE; NEUROENDOCRINE CELLS; PRECANCEROUS CONDITIONS; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80054752003     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1015-z     Document Type: Article

References (11)

1. AJ Cohen TE King LB Gilman, et al. 1998 High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells Am J Respir Crit Care Med 158 1593 1599 9817713 1:STN:280: DyaK1M%2FjsVOnug%3D%3D
2. Davis SJ, Gosney JR, Hansell DM, Wells AU, Bois RM, Burke MM, Sheppard M, Nicholson AG (2006) Diffuse idiopathic neuroendocrine cell hyperplasia: an under recognised spectrum of disease. Thorax 62(3):248-252
3. Ginsberg R (2000) Carcinoid tumors. In: Shields TW, LoCicero J, Ponn RB (eds) General thoracic surgery, vol 109. Lippincott Williams and Willkins, Philadelphia, pp 1493-1504
4. VE Gould RI Linnoila VA Memoli, et al. 1983 Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms Lab Invest 49 519 537 6138458 1:STN:280:DyaL2c%2FjslOnuw%3D%3D (Pubitemid 14248254)
5. EC Johney J Pfannschmidt RJ Rieker, et al. 2006 Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and a typical carcinoid tumor J Thorac Cardiovasc Surg 131 1207 1208 16678628 10.1016/j.jtcvs.2005.12.064
6. KM Kerr 2001 Pulmonary preinvasive neoplasia J Clin Pathol 54 257 271 11304841 10.1136/jcp.54.4.257 1:STN:280:DC%2BD3M3ivFKqtA%3D%3D (Pubitemid 32270007)
7. RR Miller R Muller 1995 Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors Am J Surg Pathol 19 653 658 7755151 10.1097/00000478-199506000-00005 1:STN:280:DyaK2M3nsVOrug%3D%3D
8. K Oberg 1991 The role of interferons in the management of carcinoid tumors Acta Oncol 30 519 522 1854509 10.3109/02841869109092411 1:STN:280:DyaK3MzgslOrsA%3D%3D
9. L Saltz 1993 Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors Cancer 72 244 248 8389666 10.1002/1097-0142(19930701)72:1<244::AID-CNCR2820720143>3.0.CO;2-Q 1:STN:280:DyaK3s3osVGrsA%3D%3D (Pubitemid 23182080)
10. J Swigris S Ghamande T Rice C Farver 2005 Diffuse idiopathic neuroendocrine cell hyperplasia: an interstitial lung disease with airway obstruction J Bronchol 12 62 65 10.1097/01.laboratory.0000147030.83001.3c (Pubitemid 40110732)
11. Travis WD, Colby TV, Corrin B, Shimosato Y et al. (1999) World Health Organization international histological classification of tumors: histological typing of lung and pleural tumors. Springer, New York